Meeting
Abstract Number: 485
SHM Converge 2021
Case Presentation: Immunotherapy is an emerging therapeutic option in the field of oncology. Dermatological toxicities are the most prevalent immune-related adverse events associated with immunotherapy. Herein, we report a case of a 60-year-old male who developed localized bullous pemphigoid after nearly a year of treatment with a PD-1 inhibitor, nivolumab, for metastatic renal cell carcinoma. […]
Abstract Number: 522
SHM Converge 2024
Case Presentation: An 80-year old woman with a PMH of a hemorrhagic R thalamic CVA, CKD3, HTN, HLD, T2DM presents for weakness and fevers in the setting of a 1 month long diffuse rash. The rash began on her legs, but spread to gluteal region, chest, arms, and palms/soles. The lesions started as blisters that […]
Abstract Number: 629
SHM Converge 2023
Case Presentation: Our patient is a 66-year-old man, a former 100-pack year smoker, with a history of hypertension, gastroesophageal reflux, emphysema, who was diagnosed in September of 2019 with stage IV squamous cell lung cancer (PD-L1 0%). He was initiated on concurrent radiation with carboplatin and nab-paclitaxel. He had a partial response to this treatment […]
Abstract Number: 1020
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 76-year-old man with history of diabetes mellitus, atrial fibrillation, colonic adenoma, and recent self-reported bed bug infestation presents with one month of pruritic rash. On interview, he also endorses progressive edema, dyspnea on exertion, orthopnea, as well as 5 days of melena. Admission exam is notable for anasarca and diffuse, tense fluid-filled […]